Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis
2011 ◽
Vol 22
(3)
◽
pp. 138-143
◽
2018 ◽
Vol 79
(3)
◽
pp. AB89
Keyword(s):
Keyword(s):
2017 ◽
Vol 1
◽
pp. s6
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2018 ◽
Vol 79
(3)
◽
pp. AB88
Keyword(s):